The MCRN assists the discovery and evaluation of new drugs through experimental studies of promising compounds, including pharmacokinetic (PK) and pharmacodynamic (PD) studies.
Due to the requirements of many of these studies, the MCRN works closely with Clinical Research Facilities (CRFs) and other experienced units with access to highly specialised research teams and advanced equipment.
If you have any questions on Experimental Medicine, please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it or if your enquiry relates to a company study, please click here for more information.